IP Library Granted Patent US 11,767,547
Granted Patent B2
US 11,767,547 · App. 16/592,707 · Granted Sep 26, 2023

Nucleic acid amplification

Inventors: Kamila Belhocine (Fremont, CA); Josephine Lee (Hayward, CA); Pranav Patel (Fremont, CA); Aaron Richardson (Palo Alto, CA); Scott Tabakman (Palo Alto, CA)
Assignee: Labrador Diagnostics LLC
C12P19/34C12Q1/686
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,767,547
App. No.
16/592,707
Granted
Sep 26, 2023
Kind
B2
Abstract

Methods and compositions for the amplification of nucleic acids and generation of concatemers are disclosed. Amplification methods provided herein may be performed under isothermal conditions. Methods and compositions may include reagents such as nucleic acid polymerases and primers.

Claims (35)

1. A reaction mixture comprising:

a polynucleotide template, a first primer, and a second primer, wherein:

the polynucleotide template comprises a first portion, a second portion and a third portion, wherein the third portion is situated in the polynucleotide template between the first portion and the second portion;

the first primer comprises a first region and a second region, wherein the first region comprises a 5′ end of the primer, the second region comprises a 3′ end of the primer, and the second region is complementary to the first portion of the polynucleotide template;

the second primer comprises a first region and a second region, wherein the first region comprises a 5′ end of the primer, the second region comprises a 3′ end of the primer, and the second region is complementary to a sequence which is complementary to the second portion of the polynucleotide template;

the first region of the first primer is complementary to the first region of the second primer; and

the first region of the second primer is complementary to the third portion of the polynucleotide template.

2. The reaction mixture of claim 1 , wherein the reaction mixture further comprises a DNA polymerase having strand-displacement activity.

3. The reaction mixture of claim 1 , wherein the reaction mixture further comprises a reverse transcriptase.

4. The reaction mixture of claim 1 , wherein the reaction mixture further comprises a nucleic acid dye.

5. The reaction mixture of claim 1 , wherein the reaction mixture further comprises nucleotides and buffer.

6. The reaction mixture of claim 1 , wherein the polynucleotide template is a DNA strand.

7. The reaction mixture of claim 1 , wherein the polynucleotide template is an RNA strand.

8. The reaction mixture of claim 1 , wherein the polynucleotide template is part of a duplex DNA molecule.

9. The reaction mixture of claim 1 , wherein the first portion and second portion of the polynucleotide template are each between 6 and 30 nucleotides in length.

10. The reaction mixture of claim 1 , wherein the third portion of the polynucleotide template is between 4 and 14 nucleotides in length.

11. A kit for the amplification of a polynucleotide template, the kit comprising:

a first primer and a second primer, wherein:

the first primer comprises a first region and a second region, wherein the first region comprises a 5′ end of the primer, the second region comprises a 3′ end of the primer, and the second region is complementary to a first portion of the polynucleotide template;

the second primer comprises a first region and a second region, wherein the first region comprises a 5′ end of the primer, the second region comprises a 3′ end of the primer, and the second region is complementary to a sequence which is complementary to a second portion of the polynucleotide template;

the first region of the first primer is complementary to the first region of the second primer; and

the first region of the second primer is complementary to a third portion of the polynucleotide template, wherein the third portion is situated in the polynucleotide template between the first portion and the second portion.

12. The kit of claim 11 , further comprising:

a third primer, and a fourth primer, wherein:

the third primer comprises a first region and a second region, wherein the first region comprises a 5′ end of the primer, the second region comprises a 3′ end of the primer, and the second region is complementary to the first portion of the polynucleotide template;

the fourth primer comprises a first region and a second region, wherein the first region comprises a 5′ end of the primer, the second region comprises a 3′ end of the primer, and the second region is complementary to a sequence which is complementary to a second portion of the polynucleotide template;

the first region of the third primer is complementary to the first region of the fourth primer; and

the nucleotide sequence of the first region of the first primer differs from the nucleotide sequence of first region of the third primer by a single nucleotide.

13. The kit of claim 12 , wherein the first region of the fourth primer is complementary to a third portion of the polynucleotide template, wherein the third portion is situated in the polynucleotide template between the first portion and the second portion.

14. The kit of claim 11 , wherein the polynucleotide template is a DNA strand.

15. The kit of claim 11 , wherein the polynucleotide template is an RNA strand.

16. The kit of claim 11 , wherein the first portion and second portion of the polynucleotide template are each between 6 and 30 nucleotides in length.

17. The kit of claim 12 , wherein the third portion of the polynucleotide template is between 4 and 14 nucleotides in length.

18. The kit of claim 11 , wherein the number of copies of the polynucleotide template in the reaction mixture is increased at least 10-fold within 60 minutes of initiation of the method.

19. The kit of claim 18 , wherein the reaction mixture is incubated without thermocycling.

Assignments (3)
CHANGE OF NAME Recorded Apr 15, 2020
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052410/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 052385/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2020
From: BELHOCINE, KAMILA; LEE, JOSEPHINE; PATEL, PRANAV; RICHARDSON, AARON; TABAKMAN, SCOTT
To: THERANOS, INC.
Reel/Frame 052354/0307 →
Continuity (13)
Continuation 14880521 · Oct 12, 2015
Continuation PCTUS2014056151 · Sep 17, 2014
Continuation 14214850 · Mar 15, 2014
Continuation In Part PCTUS2014030034 · Mar 15, 2014
Continuation In Part 14214850 · Mar 15, 2014
Continuation In Part 14546998 · Nov 18, 2014
Continuation PCTUS2014030034 · Mar 15, 2014
Continuation In Part 14850608 · Sep 10, 2015
Continuation In Part PCTUS2014030034 · Mar 15, 2014
Provisional Application 62001050 · May 20, 2014
Provisional Application 61908027 · Nov 22, 2013
Provisional Application 61800606 · Mar 15, 2013
Related Publication 20210332400A1 · Oct 28, 2021